Clinical Trial Update: VA111913 TS: First in Human Study [Phase 1]

View source ↗

Summary

This update reports the completion of the first-in-human Phase 1 study of VA111913 TS for dysmenorrhea conducted by Vantia Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• VA111913 TS

Snippet

Sponsor: Vantia Ltd | Conditions: Dysmenorrhea | Phase 1 | Status: COMPLETED